Contract facts
FederalPMO FUNDING, CLIN 9002 MSSR (1 MONTH), OPTION 6,JANUARY 2022, $33,534.95 PER MONTH is a federal award for 6973gh Franchise Acquisition Svcs held by Raytheon Company. Estimated value $1.7M ($1.6M obligated). Current period of performance ends Aug 3, 2023. Place of performance: MARLBOROUGH MA.
PMO FUNDING, CLIN 9002 MSSR (1 MONTH), OPTION 6,JANUARY 2022, $33,534.95 PER MONTH
Recompete timing
PublicCurrent PoP ended Aug 3, 2023 (1114 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordRaytheon Company — $4.8B obligated across 498 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 6973GH22F00404?
6973GH22F00404 (PMO funding CLIN 9002 MSSR (1) is a 6973gh Franchise Acquisition Svcs award with a potential value of $1.7M, currently held by Raytheon Company. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 6973GH22F00404?
6973gh Franchise Acquisition Svcs awarded 6973GH22F00404 to Raytheon Company (potential $1.7M).
Who is the incumbent on 6973GH22F00404?
Raytheon Company is the incumbent with $4.8B across 498 related awards in SCOUT’s public footprint. The current period of performance ends Aug 3, 2023.
When does Raytheon Company’s 6973GH22F00404 come up for recompete?
SCOUT tracks a period-of-performance end of Aug 3, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.